Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
38%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
THNR
20
HOLDINGS
30%
ALSO IN PPH
PPH
26
HOLDINGS
26%
ALSO IN THNR
SECTOR DRIFT (THNR minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.4% | 16.7% | 11.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | 9.1% | 6.1% | 6.1% |
|
MERCK & CO. INC. | 5.5% | 6.4% | 5.5% |
|
ABBVIE INC | 5.7% | 5.0% | 5.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.6% | 5.0% | 5.0% |
THNR Overweight Relative to PPH
|
REGENERON PHARMACEUTICALS | 7.8% |
|
AMGEN INC | 6.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.6% |
|
GILEAD SCIENCES INC | 5.3% |
 |
INNOVENT BIOLOGICS, INC. | 5.2% |
 |
ROCHE HOLDING LTD | 5.0% |
 |
CHINA PHARMACEUTICAL GROUP | 4.9% |
|
SHIONOGI & CO LTD | 4.3% |
|
HIMS & HERS HEALTH, INC. CLASS A | 3.3% |
|
NOVO-NORDISK A/S-SPONS ADR | 3.0% |
THNR Underweight Relative to PPH
|
JOHNSON & JOHNSON | -11.6% |
|
NOVARTIS AG-ADR | -7.9% |
|
ELI LILLY & CO | -5.3% |
 |
SANOFI-AVENTIS-ADR | -4.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.4% |
|
MCKESSON CORP | -4.4% |
|
BRISTOL-MYERS SQUIBB CO | -4.4% |
|
ZOETIS INC | -4.3% |
|
CENCORA INC | -3.7% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% |